[Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Pediatric Association, the National AIDS Plan and the Spanish Gynecology and Obstetrics Society].
Iribarren
J A
JA
GESIDA-SEIMC, Asociacion Espanola de Pediatria, Spain.
Ramos
J T
JT
Guerra
L
L
Coll
O
O
de José
M I
MI
Domingo
P
P
Fortuny
C
C
Miralles
P
P
Parras
F
F
Peña
J M
JM
Rodrigo
C
C
Vidal
R
R
D015492:AIDS Serodiagnosis; D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000140:Acidosis, Lactic / Q000139:chemically induced / Q000453:epidemiology; D000328:Adult; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D001942:Breast Feeding / Q000009:adverse effects; D002585:Cesarean Section; D002986:Clinical Trials as Topic; D036861:Delivery, Obstetric; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D005192:Family Health; D005260:Female; D005315:Fetal Diseases / Q000209:etiology / Q000821:virology; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D007258:Informed Consent; D008297:Male; D008431:Maternal-Fetal Exchange; D009374:Neoplasms, Experimental / Q000139:chemically induced; D016742:Preconception Care; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000453:epidemiology; D011295:Prenatal Care; D051381:Rats; D012099:Reproductive Techniques; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013030:Spain / Q000453:epidemiology; D019562:Viral Load
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase